276 related articles for article (PubMed ID: 25170834)
21. The role of autophagy in THP-1 macrophages resistance to HIV- vpr-induced apoptosis.
Zhou HY; Zheng YH; He Y; Chen Z; He B
Exp Cell Res; 2017 Feb; 351(1):68-73. PubMed ID: 28057470
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Vpr Induces Degradation of Gelsolin, a Myeloid Cell-Specific Host Factor That Reduces Viral Infectivity by Inhibiting the Expression and Packaging of the HIV-1 Env Glycoprotein.
Fabryova H; Kao S; Sukegawa S; Miyagi E; Taylor L; Ferhadian D; Saito H; Schaal H; Hillebrand F; Strebel K
mBio; 2023 Feb; 14(1):e0297322. PubMed ID: 36602307
[TBL] [Abstract][Full Text] [Related]
23. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.
Jacquot G; Le Rouzic E; David A; Mazzolini J; Bouchet J; Bouaziz S; Niedergang F; Pancino G; Benichou S
Retrovirology; 2007 Nov; 4():84. PubMed ID: 18039376
[TBL] [Abstract][Full Text] [Related]
24. Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.
Datta PK; Deshmane S; Khalili K; Merali S; Gordon JC; Fecchio C; Barrero CA
Cell Cycle; 2016 Sep; 15(17):2288-98. PubMed ID: 27245560
[TBL] [Abstract][Full Text] [Related]
25. RIG-I detects HIV-1 infection and mediates type I interferon response in human macrophages from patients with HIV-1-associated neurocognitive disorders.
Wang MQ; Huang YL; Huang J; Zheng JL; Qian GX
Genet Mol Res; 2015 Oct; 14(4):13799-811. PubMed ID: 26535695
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.
Vázquez N; Greenwell-Wild T; Marinos NJ; Swaim WD; Nares S; Ott DE; Schubert U; Henklein P; Orenstein JM; Sporn MB; Wahl SM
J Virol; 2005 Apr; 79(7):4479-91. PubMed ID: 15767448
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 27, Similar to Interferons, Modulates Gene Expression of Tripartite Motif (TRIM) Family Members and Interferes with Mayaro Virus Replication in Human Macrophages.
Hernández-Sarmiento LJ; Tamayo-Molina YS; Valdés-López JF; Urcuqui-Inchima S
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932287
[TBL] [Abstract][Full Text] [Related]
28. Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells.
Kim N; Kukkonen S; Martinez-Viedma Mdel P; Gupta S; Aldovini A
Blood; 2013 May; 121(20):4090-100. PubMed ID: 23535064
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors.
Federico M; Percario Z; Olivetta E; Fiorucci G; Muratori C; Micheli A; Romeo G; Affabris E
Blood; 2001 Nov; 98(9):2752-61. PubMed ID: 11675348
[TBL] [Abstract][Full Text] [Related]
30. Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis.
Busca A; Saxena M; Kumar A
J Biol Chem; 2012 Apr; 287(18):15118-33. PubMed ID: 22403404
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
32. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.
Taneichi D; Iijima K; Doi A; Koyama T; Minemoto Y; Tokunaga K; Shimura M; Kano S; Ishizaka Y
J Neuroimmune Pharmacol; 2011 Jun; 6(2):177-87. PubMed ID: 21519849
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency.
Hoshino S; Konishi M; Mori M; Shimura M; Nishitani C; Kuroki Y; Koyanagi Y; Kano S; Itabe H; Ishizaka Y
J Leukoc Biol; 2010 Jun; 87(6):1133-43. PubMed ID: 20145198
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
[TBL] [Abstract][Full Text] [Related]
35. Interferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders.
Zhao L; Huang Y; Tian C; Taylor L; Curthoys N; Wang Y; Vernon H; Zheng J
PLoS One; 2012; 7(3):e32995. PubMed ID: 22479354
[TBL] [Abstract][Full Text] [Related]
36. Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages.
Iordanskiy S; Zhao Y; DiMarzio P; Agostini I; Dubrovsky L; Bukrinsky M
Blood; 2004 Sep; 104(6):1867-72. PubMed ID: 15166037
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.
Muthumani K; Hwang DS; Choo AY; Mayilvahanan S; Dayes NS; Thieu KP; Weiner DB
Int Immunol; 2005 Feb; 17(2):103-16. PubMed ID: 15611322
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.
Perwitasari O; Cho H; Diamond MS; Gale M
J Biol Chem; 2011 Dec; 286(52):44412-23. PubMed ID: 22065572
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
Muthumani K; Kudchodkar S; Papasavvas E; Montaner LJ; Weiner DB; Ayyavoo V
J Leukoc Biol; 2000 Sep; 68(3):366-72. PubMed ID: 10985253
[TBL] [Abstract][Full Text] [Related]
40. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.
Casey Klockow L; Sharifi HJ; Wen X; Flagg M; Furuya AK; Nekorchuk M; de Noronha CM
Virology; 2013 Sep; 444(1-2):191-202. PubMed ID: 23849790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
